MarketWatch Automation
Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.32% inched 0.01% higher to $167.58 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.09% falling 0.72% to 4,274.04 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.04% falling 0.50% to 33,980.32. This was the stock's third consecutive day of gains. Johnson & Johnson closed $19.11 below its 52-week high ($186.69), which the company reached on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +0.04% fell 0.70% to $325.50, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.95% rose 0.50% to $91.04, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.31% fell 1.18% to $49.27. Trading volume (7.4 M) eclipsed its 50-day average volume of 6.8 M.
Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Add to watchlist
JNJ
Add to watchlist
DJIA
Add to watchlist
RHHVF
Add to watchlist
MRK
Add to watchlist
PFE
